[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Hereditary Angioedema Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

June 2023 | 116 pages | ID: GBECF9826BACEN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question

Hereditary angioedema is a rare autosomal dominant disorder and has disease epidemiology of one individual per 10,000 - 50,000 without major sex or ethnic differences.

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Hereditary Angioedema market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Hereditary Angioedema market are covered in Chapter 9:
Ionis Pharmaceuticals
CSL
Teva Pharmaceutical Industries
Merck & Co., Inc.
Cipla, Inc.
Shire
Sanofi N.V.
Pharming Group
ioCryst Pharmaceuticals
iBio

In Chapter 5 and Chapter 7.3, based on types, the Hereditary Angioedema market from 2017 to 2027 is primarily split into:
Type I HAE
Type II HAE
Type III HAE

In Chapter 6 and Chapter 7.4, based on applications, the Hereditary Angioedema market from 2017 to 2027 covers:
Hospitals
clinics
Research centers

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa

Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Hereditary Angioedema market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Hereditary Angioedema Industry.

2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.

3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 HEREDITARY ANGIOEDEMA MARKET OVERVIEW

1.1 Product Overview and Scope of Hereditary Angioedema Market
1.2 Hereditary Angioedema Market Segment by Type
  1.2.1 Global Hereditary Angioedema Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Hereditary Angioedema Market Segment by Application
  1.3.1 Hereditary Angioedema Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Hereditary Angioedema Market, Region Wise (2017-2027)
  1.4.1 Global Hereditary Angioedema Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Hereditary Angioedema Market Status and Prospect (2017-2027)
  1.4.3 Europe Hereditary Angioedema Market Status and Prospect (2017-2027)
  1.4.4 China Hereditary Angioedema Market Status and Prospect (2017-2027)
  1.4.5 Japan Hereditary Angioedema Market Status and Prospect (2017-2027)
  1.4.6 India Hereditary Angioedema Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Hereditary Angioedema Market Status and Prospect (2017-2027)
  1.4.8 Latin America Hereditary Angioedema Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Hereditary Angioedema Market Status and Prospect (2017-2027)
1.5 Global Market Size of Hereditary Angioedema (2017-2027)
  1.5.1 Global Hereditary Angioedema Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Hereditary Angioedema Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Hereditary Angioedema Market

2 INDUSTRY OUTLOOK

2.1 Hereditary Angioedema Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Hereditary Angioedema Market Drivers Analysis
2.4 Hereditary Angioedema Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Hereditary Angioedema Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Hereditary Angioedema Industry Development

3 GLOBAL HEREDITARY ANGIOEDEMA MARKET LANDSCAPE BY PLAYER

3.1 Global Hereditary Angioedema Sales Volume and Share by Player (2017-2022)
3.2 Global Hereditary Angioedema Revenue and Market Share by Player (2017-2022)
3.3 Global Hereditary Angioedema Average Price by Player (2017-2022)
3.4 Global Hereditary Angioedema Gross Margin by Player (2017-2022)
3.5 Hereditary Angioedema Market Competitive Situation and Trends
  3.5.1 Hereditary Angioedema Market Concentration Rate
  3.5.2 Hereditary Angioedema Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL HEREDITARY ANGIOEDEMA SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Hereditary Angioedema Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Hereditary Angioedema Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Hereditary Angioedema Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Hereditary Angioedema Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Hereditary Angioedema Market Under COVID-19
4.5 Europe Hereditary Angioedema Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Hereditary Angioedema Market Under COVID-19
4.6 China Hereditary Angioedema Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Hereditary Angioedema Market Under COVID-19
4.7 Japan Hereditary Angioedema Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Hereditary Angioedema Market Under COVID-19
4.8 India Hereditary Angioedema Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Hereditary Angioedema Market Under COVID-19
4.9 Southeast Asia Hereditary Angioedema Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Hereditary Angioedema Market Under COVID-19
4.10 Latin America Hereditary Angioedema Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Hereditary Angioedema Market Under COVID-19
4.11 Middle East and Africa Hereditary Angioedema Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Hereditary Angioedema Market Under COVID-19

5 GLOBAL HEREDITARY ANGIOEDEMA SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Hereditary Angioedema Sales Volume and Market Share by Type (2017-2022)
5.2 Global Hereditary Angioedema Revenue and Market Share by Type (2017-2022)
5.3 Global Hereditary Angioedema Price by Type (2017-2022)
5.4 Global Hereditary Angioedema Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Hereditary Angioedema Sales Volume, Revenue and Growth Rate of Type I HAE (2017-2022)
  5.4.2 Global Hereditary Angioedema Sales Volume, Revenue and Growth Rate of Type II HAE (2017-2022)
  5.4.3 Global Hereditary Angioedema Sales Volume, Revenue and Growth Rate of Type III HAE (2017-2022)

6 GLOBAL HEREDITARY ANGIOEDEMA MARKET ANALYSIS BY APPLICATION

6.1 Global Hereditary Angioedema Consumption and Market Share by Application (2017-2022)
6.2 Global Hereditary Angioedema Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Hereditary Angioedema Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Hereditary Angioedema Consumption and Growth Rate of Hospitals (2017-2022)
  6.3.2 Global Hereditary Angioedema Consumption and Growth Rate of clinics (2017-2022)
  6.3.3 Global Hereditary Angioedema Consumption and Growth Rate of Research centers (2017-2022)

7 GLOBAL HEREDITARY ANGIOEDEMA MARKET FORECAST (2022-2027)

7.1 Global Hereditary Angioedema Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Hereditary Angioedema Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Hereditary Angioedema Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Hereditary Angioedema Price and Trend Forecast (2022-2027)
7.2 Global Hereditary Angioedema Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Hereditary Angioedema Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Hereditary Angioedema Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Hereditary Angioedema Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Hereditary Angioedema Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Hereditary Angioedema Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Hereditary Angioedema Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Hereditary Angioedema Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Hereditary Angioedema Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Hereditary Angioedema Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Hereditary Angioedema Revenue and Growth Rate of Type I HAE (2022-2027)
  7.3.2 Global Hereditary Angioedema Revenue and Growth Rate of Type II HAE (2022-2027)
  7.3.3 Global Hereditary Angioedema Revenue and Growth Rate of Type III HAE (2022-2027)
7.4 Global Hereditary Angioedema Consumption Forecast by Application (2022-2027)
  7.4.1 Global Hereditary Angioedema Consumption Value and Growth Rate of Hospitals(2022-2027)
  7.4.2 Global Hereditary Angioedema Consumption Value and Growth Rate of clinics(2022-2027)
  7.4.3 Global Hereditary Angioedema Consumption Value and Growth Rate of Research centers(2022-2027)
7.5 Hereditary Angioedema Market Forecast Under COVID-19

8 HEREDITARY ANGIOEDEMA MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Hereditary Angioedema Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Hereditary Angioedema Analysis
8.6 Major Downstream Buyers of Hereditary Angioedema Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Hereditary Angioedema Industry

9 PLAYERS PROFILES

9.1 Ionis Pharmaceuticals
  9.1.1 Ionis Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Hereditary Angioedema Product Profiles, Application and Specification
  9.1.3 Ionis Pharmaceuticals Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 CSL
  9.2.1 CSL Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Hereditary Angioedema Product Profiles, Application and Specification
  9.2.3 CSL Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Teva Pharmaceutical Industries
  9.3.1 Teva Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Hereditary Angioedema Product Profiles, Application and Specification
  9.3.3 Teva Pharmaceutical Industries Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Merck & Co., Inc.
  9.4.1 Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Hereditary Angioedema Product Profiles, Application and Specification
  9.4.3 Merck & Co., Inc. Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Cipla, Inc.
  9.5.1 Cipla, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Hereditary Angioedema Product Profiles, Application and Specification
  9.5.3 Cipla, Inc. Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Shire
  9.6.1 Shire Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Hereditary Angioedema Product Profiles, Application and Specification
  9.6.3 Shire Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Sanofi N.V.
  9.7.1 Sanofi N.V. Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Hereditary Angioedema Product Profiles, Application and Specification
  9.7.3 Sanofi N.V. Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Pharming Group
  9.8.1 Pharming Group Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Hereditary Angioedema Product Profiles, Application and Specification
  9.8.3 Pharming Group Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 ioCryst Pharmaceuticals
  9.9.1 ioCryst Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Hereditary Angioedema Product Profiles, Application and Specification
  9.9.3 ioCryst Pharmaceuticals Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 iBio
  9.10.1 iBio Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Hereditary Angioedema Product Profiles, Application and Specification
  9.10.3 iBio Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES

Figure Hereditary Angioedema Product Picture
Table Global Hereditary Angioedema Market Sales Volume and CAGR (%) Comparison by Type
Table Hereditary Angioedema Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Hereditary Angioedema Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Hereditary Angioedema Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Hereditary Angioedema Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Hereditary Angioedema Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Hereditary Angioedema Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Hereditary Angioedema Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Hereditary Angioedema Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Hereditary Angioedema Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Hereditary Angioedema Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Hereditary Angioedema Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Hereditary Angioedema Industry Development
Table Global Hereditary Angioedema Sales Volume by Player (2017-2022)
Table Global Hereditary Angioedema Sales Volume Share by Player (2017-2022)
Figure Global Hereditary Angioedema Sales Volume Share by Player in 2021
Table Hereditary Angioedema Revenue (Million USD) by Player (2017-2022)
Table Hereditary Angioedema Revenue Market Share by Player (2017-2022)
Table Hereditary Angioedema Price by Player (2017-2022)
Table Hereditary Angioedema Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Hereditary Angioedema Sales Volume, Region Wise (2017-2022)
Table Global Hereditary Angioedema Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Hereditary Angioedema Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Hereditary Angioedema Sales Volume Market Share, Region Wise in 2021
Table Global Hereditary Angioedema Revenue (Million USD), Region Wise (2017-2022)
Table Global Hereditary Angioedema Revenue Market Share, Region Wise (2017-2022)
Figure Global Hereditary Angioedema Revenue Market Share, Region Wise (2017-2022)
Figure Global Hereditary Angioedema Revenue Market Share, Region Wise in 2021
Table Global Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Hereditary Angioedema Sales Volume by Type (2017-2022)
Table Global Hereditary Angioedema Sales Volume Market Share by Type (2017-2022)
Figure Global Hereditary Angioedema Sales Volume Market Share by Type in 2021
Table Global Hereditary Angioedema Revenue (Million USD) by Type (2017-2022)
Table Global Hereditary Angioedema Revenue Market Share by Type (2017-2022)
Figure Global Hereditary Angioedema Revenue Market Share by Type in 2021
Table Hereditary Angioedema Price by Type (2017-2022)
Figure Global Hereditary Angioedema Sales Volume and Growth Rate of Type I HAE (2017-2022)
Figure Global Hereditary Angioedema Revenue (Million USD) and Growth Rate of Type I HAE (2017-2022)
Figure Global Hereditary Angioedema Sales Volume and Growth Rate of Type II HAE (2017-2022)
Figure Global Hereditary Angioedema Revenue (Million USD) and Growth Rate of Type II HAE (2017-2022)
Figure Global Hereditary Angioedema Sales Volume and Growth Rate of Type III HAE (2017-2022)
Figure Global Hereditary Angioedema Revenue (Million USD) and Growth Rate of Type III HAE (2017-2022)
Table Global Hereditary Angioedema Consumption by Application (2017-2022)
Table Global Hereditary Angioedema Consumption Market Share by Application (2017-2022)
Table Global Hereditary Angioedema Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Hereditary Angioedema Consumption Revenue Market Share by Application (2017-2022)
Table Global Hereditary Angioedema Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Hereditary Angioedema Consumption and Growth Rate of clinics (2017-2022)
Table Global Hereditary Angioedema Consumption and Growth Rate of Research centers (2017-2022)
Figure Global Hereditary Angioedema Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Hereditary Angioedema Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Hereditary Angioedema Price and Trend Forecast (2022-2027)
Figure USA Hereditary Angioedema Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Hereditary Angioedema Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Hereditary Angioedema Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Hereditary Angioedema Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Hereditary Angioedema Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Hereditary Angioedema Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Hereditary Angioedema Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Hereditary Angioedema Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Hereditary Angioedema Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Hereditary Angioedema Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Hereditary Angioedema Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Hereditary Angioedema Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Hereditary Angioedema Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Hereditary Angioedema Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Hereditary Angioedema Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Hereditary Angioedema Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Hereditary Angioedema Market Sales Volume Forecast, by Type
Table Global Hereditary Angioedema Sales Volume Market Share Forecast, by Type
Table Global Hereditary Angioedema Market Revenue (Million USD) Forecast, by Type
Table Global Hereditary Angioedema Revenue Market Share Forecast, by Type
Table Global Hereditary Angioedema Price Forecast, by Type
Figure Global Hereditary Angioedema Revenue (Million USD) and Growth Rate of Type I HAE (2022-2027)
Figure Global Hereditary Angioedema Revenue (Million USD) and Growth Rate of Type I HAE (2022-2027)
Figure Global Hereditary Angioedema Revenue (Million USD) and Growth Rate of Type II HAE (2022-2027)
Figure Global Hereditary Angioedema Revenue (Million USD) and Growth Rate of Type II HAE (2022-2027)
Figure Global Hereditary Angioedema Revenue (Million USD) and Growth Rate of Type III HAE (2022-2027)
Figure Global Hereditary Angioedema Revenue (Million USD) and Growth Rate of Type III HAE (2022-2027)
Table Global Hereditary Angioedema Market Consumption Forecast, by Application
Table Global Hereditary Angioedema Consumption Market Share Forecast, by Application
Table Global Hereditary Angioedema Market Revenue (Million USD) Forecast, by Application
Table Global Hereditary Angioedema Revenue Market Share Forecast, by Application
Figure Global Hereditary Angioedema Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Hereditary Angioedema Consumption Value (Million USD) and Growth Rate of clinics (2022-2027)
Figure Global Hereditary Angioedema Consumption Value (Million USD) and Growth Rate of Research centers (2022-2027)
Figure Hereditary Angioedema Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Ionis Pharmaceuticals Profile
Table Ionis Pharmaceuticals Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ionis Pharmaceuticals Hereditary Angioedema Sales Volume and Growth Rate
Figure Ionis Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table CSL Profile
Table CSL Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CSL Hereditary Angioedema Sales Volume and Growth Rate
Figure CSL Revenue (Million USD) Market Share 2017-2022
Table Teva Pharmaceutical Industries Profile
Table Teva Pharmaceutical Industries Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Pharmaceutical Industries Hereditary Angioedema Sales Volume and Growth Rate
Figure Teva Pharmaceutical Industries Revenue (Million USD) Market Share 2017-2022
Table Merck & Co., Inc. Profile
Table Merck & Co., Inc. Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co., Inc. Hereditary Angioedema Sales Volume and Growth Rate
Figure Merck & Co., Inc. Revenue (Million USD) Market Share 2017-2022
Table Cipla, Inc. Profile
Table Cipla, Inc. Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cipla, Inc. Hereditary Angioedema Sales Volume and Growth Rate
Figure Cipla, Inc. Revenue (Million USD) Market Share 2017-2022
Table Shire Profile
Table Shire Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shire Hereditary Angioedema Sales Volume and Growth Rate
Figure Shire Revenue (Million USD) Market Share 2017-2022
Table Sanofi N.V. Profile
Table Sanofi N.V. Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi N.V. Hereditary Angioedema Sales Volume and Growth Rate
Figure Sanofi N.V. Revenue (Million USD) Market Share 2017-2022
Table Pharming Group Profile
Table Pharming Group Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pharming Group Hereditary Angioedema Sales Volume and Growth Rate
Figure Pharming Group Revenue (Million USD) Market Share 2017-2022
Table ioCryst Pharmaceuticals Profile
Table ioCryst Pharmaceuticals Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ioCryst Pharmaceuticals Hereditary Angioedema Sales Volume and Growth Rate
Figure ioCryst Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table iBio Profile
Table iBio Hereditary Angioedema Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure iBio Hereditary Angioedema Sales Volume and Growth Rate
Figure iBio Revenue (Million USD) Market Share 2017-2022




More Publications